Discovery Life Sciences, a research biobank located in Los Osos, California, agreed to acquire QualTek Molecular Laboratories, which specializes in immunohistochemistry. Financial terms were not disclosed. QualTek's acquisition significantly augments Discovery's existing histopathology services and creates a uniquely powerful suite of solutions that include one of the world's largest commercial biorepositories and biospecimen procurement networks, the HudsonAlpha Discovery sequencing and bioinformatics laboratory, and innovative flow cytometry and cell-based laboratory services.